Silstatins 1-8 and Structural Modifications: Antineoplastic Agents

Cancer Therapeutics

Silstatins 1-8 and Structural Modifications: Antineoplastic Agents

Compounds to Modulate Retinoid X Receptors

Compounds to Modulate Retinoid X Receptors

Novel Human C3 Derivatives for Therapeutic Complement Depletion

Compositions for Treatment of HER2 Positive Cancers

Anticancer Podostatin Compounds

Compounds to Modulate Retinoid X Receptors

Compounds to Modulate Retinoid X Receptors

Compounds to Modulate Retinoid X Receptors

Antibody Fusion Protein and Compositions for Targeting Cancer